Literature DB >> 6519373

Aminoglycoside-induced functional and biochemical defects in the renal cortex.

G J Kaloyanides.   

Abstract

The first site of aminoglycoside-cell interaction occurs at the plasma membrane of renal proximal tubular cells which have been shown to selectively transport and accumulate these drugs. Depression of apical membrane transport of organic base, low-molecular-weight protein, and glucose, together with loss of brush border membrane enzymes and phospholipids in the urine which results in altered phospholipid composition of this membrane, occurs early in the course of aminoglycoside administration. Less well appreciated are the alterations which occur at the basolateral membrane. These include decreased transport of organic bases, Ca2+, Na2+, and K+; increased organic acid transport; decreased activity of Na+-K+ ATPase and adenylate cyclase; decreased calcium content; and altered phospholipid composition. Many of these changes are evident within 90 min of a single injection of drug. Lysosomal dysfunction is manifested by the accumulation of phospholipids in the form of myeloid bodies consequent to the inhibition of lysosomal phospholipases by aminoglycosides. Labilization of lysosomes in vivo has been postulated to be a mechanism of cell injury. Mitochondrial dysfunction attributed to aminoglycosides includes impaired respiration, inhibition of Mg2+ binding, inhibition of Ca2+ uptake, increased permeability to monovalent cations, decreased ammoniagenesis, and decreased gluconeogenesis. However, it remains unclear how the drug gains access to mitochondria in vivo in order to initiate the functional derangements. It is evident that aminoglycosides cause multiple metabolic derangements at multiple sites within renal proximal tubular cells. At present the available evidence does not identify which, if any, of these drug effects is responsible for initiating the injury cascade. The strong possibility exists that aminoglycoside nephrotoxicity reflects the net impact of multiple minor metabolic derangements which individually are of little significance but when added together seriously compromise the cell's ability to maintain its structural and functional integrity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519373     DOI: 10.1016/0272-0590(84)90231-8

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  6 in total

1.  Correlation between renal membrane binding and nephrotoxicity of aminoglycosides.

Authors:  P D Williams; D B Bennett; C R Gleason; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

2.  Seasonal effects on the daily variations of gentamicin-induced nephrotoxicity.

Authors:  C Pariat; P Ingrand; J Cambar; E de Lemos; A Piriou; P Courtois
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 3.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Chemopreventive role of Coriandrum sativum against gentamicin-induced renal histopathological damage in rats.

Authors:  Abhijeet Lakhera; Aditya Ganeshpurkar; Divya Bansal; Nazneen Dubey
Journal:  Interdiscip Toxicol       Date:  2015-06

5.  Phytochemical, pharmacological evaluation of Morinda pubescens J.E.Sm. bark extract for nephroprotective activity.

Authors:  H D Jedage; K P Manjunath
Journal:  Ayu       Date:  2016 Jul-Dec

6.  An experimetal evaluation of nephroprotective potential of Butea monosperma extract in albino rats.

Authors:  Nisha Sonkar; Aditya Ganeshpurkar; Priyanka Yadav; Shagun Dubey; Divya Bansal; Nazneen Dubey
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.